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two decades of endovascular aneurysm repair
Christine Chung, MD, Rami Tadros, MD, Marielle Torres, BA,
Rajesh Malik, MD, Sharif Ellozy, MD, Peter Faries, MD,
Michael Marin, MD, and Ageliki G. Vouyouka, MD
Objective: Women have been under-represented in trials
that set guidelines for the management of aortic aneur-
ysms. Several studies reported inferior outcomes in women
compared with men after endovascular aneurysm repair
(EVAR). We investigated the relationship between gender
and outcomes after EVAR.
Methods: A total of 1380 consecutive patients underwent
elective EVAR from 1992 to 2012. Baseline, intraoperative,
and postoperative variables by gender were analyzed from
a prospective database.
Results: The cohort comprised 214 women (15.5%) and
1166 men (84.5%). Women were older than men at repair
(77.8 vs 74.5 years, P < .001) and had less cardiac disease (P
= .005). They had shorter (19.8  12.9 vs 26.3  14.7 mm; P
< .001) more angulated aortic necks (38.8  16.1 vs 31.2
 14.7; P < .001) and fewer iliac aneurysms (P = .002).
Women had more arterial reconstructions (iliac conduits, P
= .006; thrombolysis and thrombectomy, P = .013; patch
angioplasty, P < .001; endarterectomy, P < .001), more
perioperative complications (16.9% vs 9.1%; P = .001), and
more in-hospital days (4.1 vs 3.4 days; P = .029). Perioper-
ative mortality was equivalent (women: 2% vs men: 2.3%; P
= .73). Mean follow-up was 30.9 months. Women and men
experienced equivalent aneurysm-related deaths and
overall survival. Survival curve analysis showed endoleaks
were more likely to develop in women than men (P = .005);
however, there was no difference in rates of arterial rein-
terventions required for each gender during the follow-up
period.
Conclusions: Female gender is associated with more peri-
procedural complications, adjunctive arterial procedures,
and increased endoleaks but does not affect long-term
reinterventions or survival. Further studies are warranted to
elucidate the effect of gender on outcomes. These data*Full articles available online at www.jvascsurg.org
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http://dx.doi.org/10.1016/S1078-5884(15)00141-0should be considered when selecting EVAR for men and
women.Role of type II endoleak in sac regression after
endovascular repair of infrarenal abdominal aortic
aneurysms
Jared Kray, DO, Spencer Kirk, DO, Jan Franko, MD, PhD, and
David K. Chew, MD
Objective: Endovascular repair (EVAR) of infrarenal aortic
aneurysms (AAA) is increasingly used in patients with suit-
able aortic morphology conforming to device-speciﬁc
instructions for use. Despite improvements in graft design,
type II endoleak (EL-2) from the inferior mesenteric artery
(EL-IMA) or the lumbar artery (EL-LA) remains the Achilles’
heel of EVAR. The objective of this study was to evaluate
the natural history of the AAA sac after EVAR. We
hypothesized that persistent EL-2 would be associated with
inferior AAA sac volume regression.
Methods: A retrospective analysis was performed on all
nonruptured AAA treated by elective EVAR using Food and
Drug Administration-approved endografts from January 2005
to December 2008 in our facility. Review of medical records
and preoperative and follow-up computed tomography
angiograms at 1, 6, and 12 months was performed. Patients
with type I, III, and IV endoleakswere excluded, aswere those
lost to all follow-up. AAA size and volume were analyzed
using TeraRecon software (Aquarius Intuition, Foster City,
Calif). Change in AAA sac volume was compared in patients
with and without EL-2, and with an occluded vs patent IMA.
Results: The study cohort comprised 191 patients (161 men,
30 women) with a mean age of 74 years. The mean pre-
operative AAA diameter was 5.5 cm (range, 4-11 cm), and
mean volume was 137.45 cm3. EL-2 was present in 24% at
completion of EVAR and in 9% at a mean follow-up of 6
months (range 4-8 months). Completion angiography at 1
month showed 63% of EL-2 had resolved. Those with EL-2
present at 1 month had statistically inferior sac regression
compared with those who did not (23% reduction vs 2%
increase at 1 year; P = .002). Preoperatively, the IMA was
occluded by coils or was chronically occluded in 82 patients
vs 109 patients who had a patent IMA. At the 6-month
follow-up, patients with an occluded IMA had an EL-2 rate
of 2.4% vs 14.7% in those with a patent IMA (P = .005 by t-
test). Sac volume regression was 21.8% in those with an
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by t-test). Regression in AAA sac volume was highly sig-
niﬁcant in patients with occluded IMA, at 30% vs 16% at 1
year (P = .0018 by two-sided t-test).
Conclusions: The presence of persistent EL-2 after EVAR
results in inferior AAA sac regression. A preoperatively
patent IMA is associated with increased rates of EL-2 and
inferior AAA sac regression. Consideration should be given
to preoperative occlusion of a patent IMA before EVAR.Type Ia endoleaks after fenestrated and branched
endografts may lead to component instability and
increased aortic mortality
Adrian O’Callaghan, MB, Roy K. Greenberg, MD, Matthew J.
Eagleton, MD, James Bena MS, and Tara Marie
Mastracci, MD
Objectives: Fenestrated and branched endografts allow for
proximal sealing zone extension into or above the visceral
aorta to optimize landing in healthy aorta. We describe the
incidence, causes, and implications of proximal endoleak
development in patients undergoing complex endovascular
aortic aneurysm repair.
Methods: All patients undergoing a fenestrated/branched
repair were entered onto a prospective database, and this
analysis included all those with at least one postoperative
contrast computed tomography scan. Preoperative and
postoperative three-dimensional imaging was reanalyzed to
characterize morphology and identify endoleak. A blinded
assessor used the preoperative imaging to resize the repairs
in the endoleak group and a matched cohort of patients
without endoleak. The outcome measures were proximal
endoleak development, mortality, and component stability,
and a comparison was made with all patients undergoing
complex aortic repair.
Results: From 2001 to July 2013, 969 patients underwent
repair in a physician-sponsored investigational device
exemption trial. Excluded were 24 emergency patients and
21 patients without requisite imaging, leaving 924 available
for analysis. A proximal type Ia endoleak developed in 26
patients (2.8%). Poor choice of landing zone was implicated
in most cases, with an area of sealing in the visceral aorta,
compared with the thoracic aorta, being signiﬁcantly asso-
ciated with endoleak development (P < .01). Aortic-related
mortality was signiﬁcantly higher in the endoleak group
(26.9%) than in the group without endoleak (6.2%; P =
.001). These patients also experienced a higher incidence of
component instability of 30.8% compared with 9.6% in
patients without type Ia endoleak (P < .01).
Conclusions: Fenestrated/branched endovascular repair has
a low incidence of sealing zone failure despite the
increased complexity. However, development of a proximal
endoleak destabilizes the repair and leads to increased
mortality. Increasing complexity of design seems to improve
the long-term outcome for patients requiring complex
aortic repair.Selective shunting for carotid endarterectomy in patients
with recent stroke
Sachinder Singh Hans, MD, and Irina Catanescu, BS,
Objective: Many surgeons favor routine shunting during
carotid endarterectomy (CEA) in patients with recent
stroke who otherwise prefer selective shunt placement for
other indications of CEA. We analyzed the results of CEA in
this group of patients with the strategy of selective
shunting.
Methods: A retrospective review was performed of 59
patients (group A) undergoing CEA 8 weeks of a stroke
(2000-2014) from two midsized teaching hospitals with
stroke certiﬁcation; of these, 38 patients had CEA 2
weeks and 21 other had CEA >2 weeks but <8 weeks. All
patients sustained a middle cerebral artery stroke with
70% ipsilateral internal carotid artery stenosis. Cervical
block anesthesia was used in 43 patients and general
anesthesia in 16. During the same period, 1036 CEAs were
performed for other indications (group B). All patients in
group A were evaluated by stroke neurologist with a
National Institutes of Health stroke scale score of 1 to 4 in
22 patients (minor stroke) and 5 to 15 in 37 patients
(moderate stroke). A shunt was placed if neurologic
changes (contralateral motor weakness, aphasia, loss of
consciousness) occurred with the carotid cross-clamping or
ischemic electroencephalogram changes under general
anesthesia were observed.
Results: The study population consisted of 59 patients (36
males and 23 females) in group A with mean age of 70.5 
10.7 years. Carotid duplex imaging revealed contralateral
internal carotid artery stenosis of <50% in 36 patients,
50% to 70% in 13, 71% to 99% in 9, and occlusion in 1. Ten
patients (16.9%) required shunt placement, which was
similar to the shunt in group B (11.8% for remote stroke,
10.2% for focal transient ischemic attack/monocular
blindness, and 10.9% for asymptomatic carotid stenosis).
Two patients in group A had perioperative stroke and died
(3.4% stroke/mortality). There were no incidences of per-
manent cranial nerve palsy, myocardial infarction (MI), or
hematoma requiring re-exploration in patients undergoing
CEA in group A. Postoperative complications in group B
included new neurologic deﬁcits (postoperative stroke) in
16 (1.6%), MI in 2 (0.2%), permanent cranial nerve palsy in
3 (0.3%), and re-exploration for neck hematoma in 7
(0.7%). Six patients died after CEA in group B, for a com-
bined stroke/death rate of 2.0%. Seizures after CEA for a
recent stroke occurred in three patients (5.1%) in group A
and in none in group B (P < .002). Postoperative compli-
cations (new neurologic deﬁcits, MI, cranial nerve palsy,
and re-exploration for neck hematoma) were similar in
both groups (P > .05).
Conclusions: Shunt requirement during CEA for acute stroke
is similar to other indications of CEA. Patients undergoing
CEA for recent stroke had similar incidence of postoperative
new neurologic deﬁcit/mortality, MI, and cranial nerve palsy
compared with other indications of CEA but had a higher
incidence of perioperative seizures.
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threatened limb classiﬁcation system based on Wound,
Ischemia, and foot Infection (WIfI) correlates with risk of
major amputation and time to wound healing
Luke X. Zhan, MD, PhD, Bernardino C. Branco, MD, David G.
Armstrong, DPM, MD, PhD, and Joseph L. Mills Sr, MD
Objective: The purpose of this study was to evaluate
whether the new Society for Vascular Surgery (SVS) Wound,
Ischemia, and foot Infection (WIfI) classiﬁcation system
correlates with important clinical outcomes for limb salvage
and wound healing.
Methods: A total of 201 consecutive patients with threat-
ened limbs treated from2010 to 2011 in an academicmedical
center were analyzed. These patients were stratiﬁed into
clinical stages 1 to 4 on the basis of the SVSWIfI classiﬁcation.
The SVS objective performance goals of major amputation, 1-
year amputation-free survival (AFS) rate, and wound healing
time (WHT) according to WIfI clinical stages were compared.
Results: The mean age was 58 years (79% male, 93% with
diabetes). Forty-twopatients requiredmajor amputation (21%);
159 (78%) had limb salvage. The amputation group had a sig-
niﬁcantly higher prevalence of advanced stage 4 patients (P <
.001), whereas the limb salvage group presented predom-
inantly as stages 1 to 3. Patients in clinical stages 3 and 4 had a
signiﬁcantly higher incidence of amputation (P < .001),
decreased AFS (P < .001), and delayed WHT (P < .002) com-
pared with those in stages 1 and 2. Among patients presenting
with stage 3, primarily as a result of wound and ischemia
grades, revascularization resulted in acceleratedWHT (P= .008).
Conclusions: These data support the underlying concept of the
SVS WIfI, that an appropriate classiﬁcation system correlates
with important clinical outcomes for limb salvage and wound
healing. As the clinical stage progresses, the risk of major
amputation increases, 1-year AFS declines, and WHT is pro-
longed.We further demonstrated beneﬁt of revascularization
to improve WHT in selected patients, especially those in stage
3. Future efforts are warranted to incorporate the SVS WIfI
classiﬁcation into clinical decision-making algorithms in con-
junction with a comorbidity index and anatomic classiﬁcation.Participation in the Vascular Quality Initiative is associated
with improved perioperative medication use, which is
associated with longer patient survival
Randall R. De Martino, MD, MS, Andrew W.Hoel, MD, Adam
W. Beck, MD, Jens Eldrup-Jorgensen, MD, John W. Hallett,MD, Gilbert R. Upchurch, MD, Jack L. Cronenwett, MD, and
Philip P. Goodney, MD, MS
Objective: Medical management (MM) with antiplatelet
(AP) and statin therapy is recommended for most patients
undergoing vascular surgery and has been advocated by the
Vascular Quality Initiative (VQI). We analyzed the effect of
VQI participation on perioperative (preoperative and post-
operative) MM use over time and the effect of discharge
MM on patient survival.
Methods: We studied VQI patients treated with MM pre-
operatively and at discharge from 2005 to 2014, including
all elective carotid endarterectomy/carotid stenting (n =
28,092), suprainguinal/infrainguinal bypass (n = 11,362),
peripheral vascular interventions (n = 24,476), open/endo-
vascular abdominal aortic aneurysm repair (n = 13,503), and
thoracic endovascular aneurysm repair (n = 702). We
examined trends of MM use over time, as well as the effect
of duration of VQI participation on MM use. Multivariable
logistic regression analysis was performed to identify fac-
tors associated with MM use. In addition, the Cox propor-
tional hazards model was used to identify factors associated
with 5-year survival.
Results: MM with AP and statin preoperatively and post-
operatively across VQI centers improved from 55% in 2005
to 68% in 2009, with a subsequent overall decline to 62% by
2014, coincident with many new centers with lower MM
rates joining VQI in 2010. Longer center participation in VQI
was associated with improved perioperative MM overall.
This was also noted across all procedure types, with MM
increasing from 47% to 82% for aneurysm repairs and 69%
to 83% for carotid procedures from 1 to 12 years of par-
ticipation in VQI. After multivariable adjustment, centers in
VQI 3 years were 30% more likely to have patients on MM
(odds ratio, 1.3, 95% conﬁdence interval [CI], 1.3-1.4).
Importantly, discharge on AP and statin therapy was asso-
ciated with improved 5-year survival, compared with dis-
charge on neither medication (82% [95% CI, 81%-83%] vs
67% [95% CI, 62%-72%]), and an adjusted hazard ratio for
death of 0.6 (95% CI, 0.5-0.7; P < .001). Discharge on a
single medication was associated with intermediate survival
at 5 years (AP only: 77% [95% CI, 75%-79%]; statin only:
73% [95% CI, 68%-77%]).
Conclusions: These data demonstrate that MM is asso-
ciated with improved survival after a number of vascular
procedures. Importantly, VQI participation improves the use
of MM, demonstrating that involvement in an organized
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Lymphatic DisordersSubsequent arterial ischemic events in patients receiving
anticoagulant therapy for venous thromboembolism
Olga Madridano, MD, PhD, Jorge del Toro, MD, Alicia
Lorenzo, MD, PhD, Mar Martín, MD, PhD, Jorge Gómez
Cerezo, MD, PhD, Luis Hernández, MD, PhD, JoséBascuñana, MD, and Paolo Prandoni, MD, PhD, on behalf of
the RIETE Investigators
Objective: Patients with acute venous thromboembolism
(VTE) are at increased risk for the development of sub-
sequent arterial ischemic events unrelated to the diagnosis of
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risk for ischemic events during the course of anticoagulation
may help to select those who would potentially beneﬁt
from concomitant therapy with anticoagulants and
antiplatelets.
Methods: We used the Registro Informatizado de Enfer-
medad TromboEmbÃ³lica (RIETE) Registry to assess the
rate and severity of subsequent ischemic events
(ie, stroke, myocardial infarction, lower limb amputation, or
mesenteric ischemia) appearing during the course of anti-
coagulant therapy and tried to identify risk factors for these
events.
Results: From February 2009 to March 2014, 23,370
patients were recruited: 12,397 initially presenting with
pulmonary embolism (PE) and 10,973 with deep venous
thrombosis. During the course of anticoagulation (mean, 9.2
months), 597 patients developed recurrent VTE, 652 bled,
162 had ischemic events (stroke, 86; myocardial infarction,
53; limb amputation, 13; mesenteric ischemia, 11), and
2063 died. Of these, 29 patients died of recurrent PE, 83 of
bleeding, and 53 of the ischemic events. On multivariable
analysis, cancer (hazard ratio [HR], 1.77; 95% conﬁdence
interval [CI], 1.21-2.61), chronic lung disease (HR, 1.54; 95%
CI, 1.05-2.26), renal insufﬁciency (HR, 1.72; 95% CI, 1.25-
2.36), anemia (HR, 1.54; 95% CI, 1.11-2.14), prior artery
disease (HR, 1.84; 95% CI, 1.29-2.64), and diabetes (HR,
1.58; 95% CI, 1.10-2.27) independently predicted the risk
for ischemic events. Most of these variables also predicted
major bleeding (cancer, chronic lung disease, renal insufﬁ-
ciency, anemia, and prior artery disease) or recurrent PE
(cancer, chronic lung disease, anemia, and prior artery
disease).
Conclusions: In patients receiving anticoagulation for VTE,
the mortality due to PE recurrences was lower than the
mortality due to ischemic events. Most independent pre-
dictors for ischemic events were also predictors for major
bleeding and for recurrent PE.Embolization techniques for high-ﬂow arteriovenous
malformations with a dominant outﬂow vein
Allan M. Conway, MD, Khalil Qato, MD, Jennifer Drury, PA-C,
and Robert J. Rosen, MD
Objective: The aim of this study was to assess the man-
agement and outcomes of arteriovenous malformations
(AVMs) with a dominant outﬂow vein (DOV) treated with
retrograde venous embolization.
Methods: A retrospective review was performed from
November 2010 to May 2014 on all patients with a high-
ﬂow AVM and associated DOV who underwent transvenous
embolization of the DOV. Indications, techniques, compli-
cations, and outcomes were reviewed.
Results: Fourteen patients (ﬁve male; 36%) underwent
transvenous embolization of high-ﬂow AVMs with a DOV.
Median age was 41.6 years (15.7-65.8 years). The AVM was
located on an extremity in eight patients (57%) and in the
pelvis in six patients (43%). The indication for the procedure
was pain in 11 patients (79%), swelling in 3 patients (21%), a
nonhealing wound in 1 patient (7%), and impotence in 1
patient (7%).Themedian number of prior procedures to treat
the AVM was 2.5 (0-13). Transvenous embolization with coils
was performed in 13 patients (93%). The Amplatzer vascular
plug and Amplatzer septal occluder (St. Jude Medical, St.
Paul, Minn) were used in four patients (29%). Concurrent
percutaneous puncture embolization of the AVM nidus was
used in seven patients (50%) and transcatheter arterial
embolization in eight patients (57%). Technical angiographic
success was seen in all patients. Five patients (36%) experi-
enced a complete response to treatment, whereas eight
(57%) experienced a partial response. Seven patients (50%)
required further procedures for residual symptoms.
Conclusions: AVMs with a DOV can be successfully treated
by a transvenous approach. Percutaneous puncture embo-
lization of the nidus or draining vein and transcatheter
arterial embolization may assist in reducing ﬂow.
